
You can waste a considerable amount of time when reviewing and editing draft documents, particularly when it is being done by an inexperienced team. When you send a ‘raw’ text out to a team for review you can multiply the number of ours you expect to spend on a manuscript by the number of people on the review team.
Your reviewers may also have their own writing style and poorly prepared documents (not ready for circulation) can result in heavy re-writes by your reviewers. This not only has the potential to waste their time but also your time navigating how best to combine additional text and possible tables/figures into the work returned by the other members of the review team.
I know I have my own exacting requirements when I review draft documents and also like to provide ‘training’ to the review team, explaining the choices you have made. It may seem somewhat nonsensical, but I may even add edits and comments to sections that I ask to be removed. There is such a potential for all parties to burn time. There are few texts where I don’t provide comment of some form or another. In response I have developed a structured approach that has served me well in providing timely reviews. To be clear, I only use these techniques on documents Niche has been employed to deliver and fir with our clearly defined writing and editing services within appropriate ethical boundries relating to contributions made to documents.
Research review: involves evaluating various aspects of the research including whether the literature of the field has been interpreted correctly, whether the methods used were appropriate, correct use of the methods (including any statistical analysis) and the results are clearly presented. It is also important to cross reference the conclusions against the projects objectives, endpoints and whether the conclusions drawn from the results are robust.
Document structure: Addressing the flow of the document – effectively its storytelling. This tends to consider the larger structural aspects of a document. Interrogations includes:
Text editing: This includes phrasing, transitions between paragraphs, and grammar usage. In addition, the process involves cross referencing links to tables, figures and appendices and finalising the references. The order you address these different aspects can be down to personal preference. As you tend to be closer to document completion when you get to text editing, it can be useful to adopt a structured approach: structural components (tables and figures), punctuation and abbreviations and finally grammar.
This approach may not necessarily be considered as addressing the aspects of the document in order of their importance, rather they are addressed in order they are most likely to extend the review and finalisation process. Clearly, all three aspects are critical to produce a high-quality document – but, rather, they are ordered according to how disruptive the changes at each phase would be to the other aspects of document development.
It can be difficult to coordinate larger editing teams when you are trying to adopt a considered, time efficient three-phase approach to editing. It is far too easy to start line editing a manuscript and miss the larger fundamental problems with the research or the structure of the document. Reviewers often get to the end of the document and find that they have made a lot of comments and conclude, “that’s enough changes for one round of editing,” and fail to address these other, larger issues. For that reason, it can sometimes be best to identify a smaller review group who can perform a first research review edit. Only distributing to the wider team once all the kinks have been ironed out.


3rd August 2014
- Tim Hardman
1st July 2019
- Tim Hardman
18th April 2019
- Tim Hardman
17th January 2018
- Tim Hardman
4th January 2019
- Tim Hardman
2nd November 2023
- Tim Hardman
19th October 2018
- Tim Hardman
31st October 2021
- Tim Hardman
In the past, Halloween has meant the end of the crop and the start of the dark, cold winter.
23rd May 2023
- Tim Hardman
I have never been great at conferences. People don’t believe me but I am painfully shy and far too worried about what.
11th May 2018
- Tim Hardman
Our team are exploring different and novel ways for young people to enter the pharmaceutical industry.
5th August 2019
- Tim Hardman
Welcome to the seventh issue of the Refractory Asthma Stratification Programme (RASP-UK) newsletter
20th April 2016
- Tim Hardman
9th October 2017
- Tim Hardman
20th April 2023
- Tim Hardman
Every year, a huge amount of scientific data is released. It's out there, but how do you find it?
7th October 2012
- Tim Hardman
12th February 2014
- Tim Hardman
27th February 2019
- Tim Hardman
4th May 2018
- Tim Hardman
9th May 2017
- Tim Hardman
12th May 2020
- Tim Hardman
30th March 2017
- Tim Hardman
3rd July 2019
- Tim Hardman
11th September 2018
- Tim Hardman
30th April 2018
- Tim Hardman
4th February 2014
- Tim Hardman
24th February 2020
- Tim Hardman
Finding the best vehicle in which to publish your research findings is a perennial challenge.
7th July 2013
- Tim Hardman
14th April 2012
- Tim Hardman
27th January 2023
- Tim Hardman
Concerns about readiness of the European Medicines Agency’s (EMA) Clinical Trials Information System persist as the.
11th November 2015
- Tim Hardman
4th May 2020
- Tim Hardman
7th July 2016
- Tim Hardman
22nd January 2019
- Tim Hardman
19th June 2018
- Tim Hardman
Experience at Niche has taught us that clinical study protocols are born in the white-hot fire
29th March 2019
- Tim Hardman
4th July 2018
- Tim Hardman
5th April 2017
- Tim Hardman
15th April 2019
- Tim Hardman
25th February 2021
- Tim Hardman
31st January 2017
- Tim Hardman
28th August 2018
- Tim Hardman
13th December 2018
- Tim Hardman
15th September 2015
- Tim Hardman
15th August 2017
- Tim Hardman
1st October 2018
- Tim Hardman
20th June 2022
- Tim Hardman
I am continually reminded that I must work toward better relationships with my sons than the one I had with my dad.
3rd March 2015
- Tim Hardman
14th March 2017
- Tim Hardman
19th November 2018
- Tim Hardman
The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)
6th September 2018
- Tim Hardman
15th April 2013
- Tim Hardman
25th April 2019
- Tim Hardman
16th May 2023
- Tim Hardman
Scientific knowledge should be accessible to all and if you are those communicating science
29th March 2021
- Tim Hardman
26th August 2015
- Tim Hardman
4th April 2023
- Tim Hardman
9th January 2016
- Tim Hardman
11th September 2015
- Tim Hardman
16th April 2018
- Tim Hardman
4th June 2020
- Tim Hardman
9th May 2017
- Tim Hardman
15th February 2018
- Tim Hardman
31st January 2020
- Tim Hardman
We all need heroes - people who can champion our cause - helping the world to understand our rationale
24th March 2025
- Tim Hardman
12th July 2022
- Tim Hardman
8th April 2019
- Tim Hardman
19th May 2023
- Tim Hardman
4th August 2021
- Tim Hardman
Since 2013 we have been sharing our understanding on key issues with friends and clients via our Insider’s Insights.
25th October 2019
- Tim Hardman
17th July 2017
- Tim Hardman
1st April 2019
- Tim Hardman
28th March 2025
- Tim Hardman
21st December 2018
- Tim Hardman
9th February 2021
- Tim Hardman
19th October 2018
- Tim Hardman
16th June 2018
- Tim Hardman
14th February 2022
- Tim Hardman
24th August 2016
- Tim Hardman
14th February 2024
- Tim Hardman
We recently encouraged writers (of all kinds) in our recent Insider’s Insight to experiment with large language.
14th August 2018
- Tim Hardman
The largest pharmaceutical companies not surprisingly rely on the largest contract research organizations
Get our latest news and publications
Sign up to our news letterResources
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
Regular Updates

